These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7635911)

  • 1. Glucocorticoid-induced osteoporosis.
    Hahn BH; Mazzaferri EL
    Hosp Pract (1995); 1995 Aug; 30(8):45-9, 52-3; discussion 53-6. PubMed ID: 7635911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
    Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
    Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-Induced Osteoporosis.
    Buckley L; Humphrey MB
    N Engl J Med; 2018 Dec; 379(26):2547-2556. PubMed ID: 30586507
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica.
    Naranjo A; López R; García-Magallón B; Cáceres L; Francisco F; Jiménez-Palop M; Ojeda-Bruno S
    Rheumatol Int; 2014 Oct; 34(10):1459-63. PubMed ID: 24728030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice. Glucocorticoid-induced bone disease.
    Weinstein RS
    N Engl J Med; 2011 Jul; 365(1):62-70. PubMed ID: 21732837
    [No Abstract]   [Full Text] [Related]  

  • 6. Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
    Giollo A; Rossini M; Bettili F; Ghellere F; Fracassi E; Idolazzi L; Gatti D; Viapiana O
    J Rheumatol; 2019 Mar; 46(3):318-322. PubMed ID: 30385701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-induced osteoporosis in systemic lupus erythematosus.
    Cunnane G; Lane NE
    Rheum Dis Clin North Am; 2000 May; 26(2):311-29, vi-vii. PubMed ID: 10768214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
    Benucci M; Dolenti S; Saviola G; Manfredi M
    Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to prevent steroid induced osteoporosis.
    Sambrook PN
    Ann Rheum Dis; 2005 Feb; 64(2):176-8. PubMed ID: 15647424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
    McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyalgia rheumatica and giant-cell arteritis.
    Praderio L; Di Comite G; Saporiti N
    N Engl J Med; 2002 Dec; 347(25):2083-5; author reply 2083-5. PubMed ID: 12494941
    [No Abstract]   [Full Text] [Related]  

  • 16. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis.
    McDonough RP; Doucette WR; Kumbera P; Klepser DG
    Value Health; 2005; 8(1):24-31. PubMed ID: 15841891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bone disease in patients on long term glucocorticoid therapy.
    Compston JE
    Gut; 1999 Jun; 44(6):770-2. PubMed ID: 10323872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of glucocorticoid induced osteoporosis].
    Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in systemic lupus erythematosus: prevention and treatment.
    Sen D; Keen RW
    Lupus; 2001; 10(3):227-32. PubMed ID: 11315358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.